Financials
- Market Capitalization 32.38 M
- Employee 25
- Founded 2000
- CEO Sandesh Seth
- Website www.actiniumpharma.com
- Headquarter Delaware, United States
- FIGI BBG000RQZ245
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
2.8
売上高対価格比率
0.88
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4392 | KYNB Kyntra Bio, Inc. - Common Stock | 8.55 USD | +0.71% | +7.95% | +23.38% | -10.09% | 34.62 M USD | ||
| 4408 | CNTX Context Therapeutics Inc. - Common Stock | 0.36 USD | 0.00% | -7.69% | -28.00% | -56.10% | 33.08 M USD | ||
| 4423 | QNCX Quince Therapeutics, Inc. - Common Stock | 31.32 USD | +2.52% | -7.99% | +7.37% | +1869.81% | 31.85 M USD | ||
| 4431 | BCTX BriaCell Therapeutics Corp. - Common Shares | 3.57 USD | +1.13% | -4.03% | +1.71% | -54.52% | 31.06 M USD |